Lipid management: Current diet and drug treatment options

https://doi.org/10.1016/S0002-9343(96)00319-1Get rights and content

Diet and drug therapy are two of the principal approaches to lipid management. The aim of both is to reduce low-density-lipoprotein (LDL) cholesterol to goal levels established by the National Cholesterol Education Program Expert Panel in its second report, based on a patient's short-term risk of a coronary event. In prescribing diet therapy, it is important to determine patients' willingness to initiate and adhere to dietary modifications, their skill at reading nutritional labels, adapting recipes, and ordering “heart-healthy” foods when eating out. Diet therapy should be directed at modifying dietary factors known to adversely influence blood cholesterol—saturated fats, cholesterol, and obesity. Diet therapy (with exercise) is not always adequate. High risk individuals with no overt coronary artery disease but with ≥2 risk factors, as well as patients with coronary artery disease, are potential candidates for drug therapy, depending on their LDL cholesterol levels. The “statins” are the drug of choice for patients with coronary disease and elevated LDL cholesterol or familial LDL-cholesterol abnormalities. These drugs increase high-density-lipoprotein (HDL) cholesterol and reduce LDL cholesterol, coronary artery disease, and total mortality. Bile acid resins lower LDL cholesterol and are often used to augment the effects of the statins and niacin. Niacin is particularly useful in the management of patients with combined hyperlipidemia and low HDL cholesterol levels. Gemfibrozil is effective in familial dysbetalipoproteinemia and is the drug of choice for patients with severely elevated serum triglycerides.

References (74)

  • MeadeTW et al.

    Haemostatic function and ischaemic heart disease: principal results of the Northwick Park Heart Study

    Lancet

    (1986)
  • MAAS investigators

    Effect of simvastatin on coronary atheroma: the Multicentre Anti-Atheroma Study (MAAS)

    Lancet

    (1994)
  • GrundySM et al.

    Influence of niacin on metabolism of cholesterol arid triglycerides in man

    J Lipid Res

    (1981)
  • KingJM et al.

    Evaluation of effects of unmodified niacin on fasting and postprandial plasma lipids in normolipidemic men with hypoalphalipoproteinemia

    Am J Med

    (1994)
  • AldermanJD et al.

    Effect of a modified, well-tolerated niacin regimen on serum total cholesterol, high density lipoprotein cholesterol and the cholesterol to high density lipoprotein ratio

    Am J Cardiol

    (1989)
  • CannerPL et al.

    Fifteen year mortality in coronary drug project patients: long-term benefit with niacin

    J Am Coll Cardiol

    (1986)
  • EtchasonJA et al.

    Niaciri-induced hepatitis: a potential side effect with low-dose time-release niacin

  • SquiresRW et al.

    Low-dose, time release nicotinic acid: effects in selected patients with low concentrations of high-density lipoprotein cholesterol

  • SuperkoHR et al.

    Effectiveness of low-dose colestipol therapy in patients with moderate hypercholesterolemia

    Am J Cardiol

    (1992)
  • KuoPT et al.

    Treatment of type III hyperlipoproteinemia with gemf brozil to retard progression of coronary artery disease

    Am Heart J

    (1988)
  • Expert Panel on Detection and Evaluation Treatment of High Blood Cholesterol in Adults. Summary of the Second Report of the National Cholesterol Education (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II)

    JAMA

    (1993)
  • McDowellMA et al.

    Energy and Macronutrient Intakes of Persons Ages 2 Months and Over in the United States: Third National Health and Nutrition Examination Survey, Phase 1, 1988–91

  • U.S.Department of Health and Human Services

    Healthy People 2000; National Health Promotion and Disease Prevention Objectives

    (1988)
  • JohnsonCL et al.

    Declining serum total cholesterol levels among US adults. The National Health and Nutrition Examination Surveys

    JAMA

    (1993)
  • SchulerG et al.

    Regular physical exercise, low-fat diet. Effects of progression on coronary artery disease

    Circulation

    (1992)
  • FieldingCJ et al.

    Effects of dietary cholesterol and fat saturation on plasma lipoproteins in an ethnically diverse population of healthy young men

    Clin Invest

    (1995)
  • DenkeMA

    Cholesterol-lowering diets. A review of the evidence

    Arch Intern Med

    (1995)
  • MensinkRP et al.

    Effect of dietary trans fatty acids on high-density and low-density lipoprotein cholesterol levels in healthy subjects

    N Engl J Med

    (1990)
  • AscherioA et al.

    Trans-fatty acids intake and risk of myocardial infarction

    Circulation

    (1994)
  • SturdevantRAL et al.

    Increased prevalence of cholelithiasis in men ingesting a serum cholesterol lowering diet

    N Engl J Med

    (1973)
  • SiscovickDS et al.

    Dietary intake and cell membrane levels of long-chain n-3 polyunsaturated fatty acids and the risk of primary cardiac arrest

    JAMA

    (1995)
  • BillmanGE et al.

    Prevention of ischemia-induced ventricular fibrillation by n-3 fatty acids

  • LeafA et al.

    Do fish oils prevent restenosis after coronary angioplasty?

    Circulation

    (1994)
  • ParthasarathyS et al.

    Low-density lipoprotein enriched in oleic acid is protected against oxidative modification: implications for dietary prevention of atherosclerosis

  • GardnerCD et al.

    Monounsaturated versus polyunsaturated dietary fat, serum lipids. A meta-analysis

    Arterioscler Thromb Vasc Biol

    (1995)
  • GargA et al.

    Comparison of a high-carbohydrate diet with a high-monounsaturated-fat diet in patients with non-insulin-dependent diabetes mellitus

    N Engl J Med

    (1988)
  • KwiterovichPO

    The role of fiber in the treatment of hypercholesterolemia in children and adolescents

    Pediatrics

    (1995)
  • Cited by (0)

    View full text